Umesh Kunte appointed CEO of Albert David
A pharma industry veteran with over three decades of experience in domestic as well as international markets
A pharma industry veteran with over three decades of experience in domestic as well as international markets
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
Acquisitions have the potential to add at least $1 billion in sales by 2028
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
Miravo to remain a Canadian controlled and operated company following closing of the transaction
The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
Subscribe To Our Newsletter & Stay Updated